Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in South Korea / NCT04592393
Active, not recruiting Not applicable

Pancreas Cancer Surveillance Using an Abbreviated MRI

NCT04592393 · tracked via the Priya Life Science South Korea tracker
Sponsor
Seoul National University Hospital
Phase
Not applicable
Started
2020-10-28
Last updated
2023-08-18

Condition(s) studied

Pancreas Cancer

Investigational drug(s) / intervention(s)

Abbreviated PB MRIGene mutation testConventional follow-up

Abbreviated PB MRI: Annual non-contrast PB MRI.

Gene mutation test: K-ras and GNAS mutation test. Being performed once as a baseline test at the enrollment.

Conventional follow-up: Any of followings: scheduled CECT, MRI, USG, EUS, tumor marker (CA 19-9) during the study period.

Study summary

This study aims to establish a prospective cohort of developing pancreas cancer and surveillance MRI protocol. With the focused surveillance protocol, we perform surveillance for pancreas cancer for five years to estimate the risk of pancreas cancer and the clinical feasibility of the surveillance MRI.

Eligibility

Sex
ALL
Min age
50 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * On follow-up due to first degree-family history of PAC * Or on follow-up for BD-IPMN (\>= 2 cm) or main-duct type IPMN (\> 5 mm) * And signed informed consent Exclusion Criteria: * Contra-indication of performing MRI * Not satisfying the selection criteria. * Previously diagnosed with pancreatic malignancy * Pregnancy or planning pregnancy

Primary outcome measure(s)

  • Detection of pancreas cancer — 1 year after the last surveillance MRI.
    number of detected pancreas cancer (resectable \& BRPC only) in surveillance MRI.

Trial sites (1)

FacilityCityRegionStatus
Seoul National University Hospital Seoul South Korea

More Seoul National University Hospital trials in South Korea

Transition of Care in Pediatric Rare Endocrine Disorders Recruiting
Impact of the Korea Early Childhood Home-visiting Intervention Active, not recruiting
Community-Based Remote Cardiac Rehabilitation Program for Pediatric Patients With Complex Congenital Heart Disease Starting soon
The Safety and Efficacy of Transanal Irrigation in Patients With Sleep Disturbance From Low Anterior Resection Syndrome After Rectal Cancer Surgery (TraLARS) Recruiting
Lung Cancer Surgery in Sarcopenia Patients With Old Age Active, not recruiting

Other trials for the same condition

Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy Enrolling by invitation
The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer Recruiting
First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer Active, not recruiting
First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04592393 on ClinicalTrials.gov ↗ ← All trials in South Korea